Trial intelligence / Profile preview

Insulin infusion versus plasma exchange for early hypertriglyceridemia-induced acute pancreatitis

ChiCTR-IIR-17012614Phase 4Recruiting

Sponsor
Peking Union Medical College Hospital
Start
Sep 2017
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, open-label trial of human insulin in acute pancreatitis (AP) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Serum triglycerides. Started Sep 2017; status: recruiting.

02

Drugs

human insulin
03

Conditions

acute pancreatitis (AP)

Beyond the preview

Go deeper on ChiCTR-IIR-17012614.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IIR-17012614.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call